State-of-the-Art: Standard of Care For Resectable NSCLC, Adjuvant Chemotherapy, Is There a Place for Neoadjuvant Chemotherapy?

Date 19 January 2018
Event ESMO Preceptorship on NSCLC Singapore November 2017
Session Session 1 Non-Metastatic Disease
Topics Thoracic malignancies
Cytotoxic agents
Therapy
Biological therapy
Presenter J. Bennouna, FR